The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
Open accessAbstract
Signal transducer and activator of transcription (STAT) 3 is one of the most complex regulators of transcription. Constitutive activation of STAT3 has been reported in many types of tumors and depends on mechanisms such as hyperactivation of receptors for pro-oncogenic cytokines and growth factors, loss of negative regulation, and excessive cytokine stimulation. In contrast, somatic STAT3 mutations are less frequent in cancer. Several oncogenic targets of STAT3 have been recently identified such as c-myc, c-Jun, PLK-1, Pim1/2, Bcl-2, VEGF, bFGF, and Cten, and inhibitors of STAT3 have been developed for cancer prevention and treatment. However, despite the oncogenic role of STAT3 having been widely demonstrated, an increasing amount of data indicate that STAT3 functions are multifaced and not easy to classify. In fact, the specific cellular role of STAT3 seems to be determined by the integration of multiple signals, by the oncogenic environment, and by the alternative splicing into two distinct isoforms, STAT3α and STAT3β. On the basis of these different conditions, STAT3 can act both as a potent tumor promoter or tumor suppressor factor. This implies that the therapies based on STAT3 modulators should be performed considering the pleiotropic functions of this transcription factor and tailored to the specific tumor type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Matsuda, T., Tanaka, Y., Ohshiro, K., & Mori, N. (2006) · Retrovirology · doi:10.1186/1742-4690-3-22 · Cited by 50
RetractedMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“Moreover, STAT3 induces the expression of hypoxia-inducible factor-1α (HIF1α), which is another key mediator of angiogenesis [94].”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“STATs are activated in the cytoplasm by Janus kinases (JAKs), a family composed of four different intracellular non-receptor tyrosine kinases, that transduce cytokine-mediated signals [7,8].”
BackgroundGage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Sahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Qian, X., Shen, Q., Goderie, S. K., He, W., Capela, A., Davis, A. A., & Temple, S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00086-6 · Cited by 865
Kim, E., Kim, M., Woo, D.-H., Shin, Y., Shin, J., Chang, N., Oh, Y. T., Kim, H., Rheey, J., Nakano, I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.008 · Cited by 806
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004747 · Cited by 740
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., & Levy, D. E. (2009) · Science · doi:10.1126/science.1171721 · Cited by 716
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Genomic Evolution of Breast Cancer Metastasis and Relapse
Yates, L. R., Knappskog, S., Wedge, D., Farmery, J. H. R., Gonzalez, S., Martincorena, I., Alexandrov, L. B., Van Loo, P., Haugland, H. K., Lilleng, P. K., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.005 · Cited by 665
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells
Chen, Z., Laurence, A., Kanno, Y., Pacher-Zavisin, M., Zhu, B.-M., Tato, C., Yoshimura, A., Hennighausen, L., & O'Shea, J. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600666103 · Cited by 653
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., et al. (1995) · Development · doi:10.1242/dev.121.5.1283 · Cited by 586
Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Wegenka, U. M., Buschmann, J., Lütticken, C., Heinrich, P. C., & Horn, F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.276 · Cited by 552
Xie, T.-X., Wei, D., Liu, M., Gao, A. C., Ali-Osman, F., Sawaya, R., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207383 · Cited by 550
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Regulation of Interleukin 12 p40 Expression through an NF-κB Half-Site
Murphy, T. L., Cleveland, M. G., Kulesza, P., Magram, J., & Murphy, K. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5258 · Cited by 482
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Kortylewski, M., Xin, H., Kujawski, M., Lee, H., Liu, Y., Harris, T., Drake, C., Pardoll, D., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.018 · Cited by 474
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Garcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S., & Sahai, E. (2006) · Current Biology · doi:10.1016/j.cub.2006.05.065 · Cited by 435
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B., & Rosen, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3041 · Cited by 415
EphB receptor activity suppresses colorectal cancer progression
Batlle, E., Bacani, J., Begthel, H., Jonkeer, S., Gregorieff, A., van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T., et al. (2005) · Nature · doi:10.1038/nature03626 · Cited by 413
Structural Biology of Shared Cytokine Receptors
Wang, X., Lupardus, P., LaPorte, S. L., & Garcia, K. C. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 408
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
Role of Stat3 in Regulating p53 Expression and Function
Niu, G., Wright, K. L., Ma, Y., Wright, G. M., Huang, M., Irby, R., Briggs, J., Karras, J., Cress, W. D., Pardoll, D., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7432-7440.2005 · Cited by 392
Multiple Routes to Astrocytic Differentiation in the CNS
Rajan, P., & McKay, R. D. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03620.1998 · Cited by 387
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
STAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Song, L., Turkson, J., Karras, J. G., Jove, R., & Haura, E. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206479 · Cited by 362
Activation and Association of Stat3 with Src in v-Src-Transformed Cell Lines
Cao, X., Tay, A., Guy, G. R., & Tan, Y. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1595 · Cited by 359
Structure, function, and regulation of STAT proteins
Lim, C. P., & Cao, X. (2006) · Molecular BioSystems · doi:10.1039/b606246f · Cited by 354
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Furtek, S. L., Backos, D. S., Matheson, C. J., & Reigan, P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00945 · Cited by 347
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Yang, J., Huang, J., Dasgupta, M., Sears, N., Miyagi, M., Wang, B., Chance, M. R., Chen, X., Du, Y., Wang, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016147107 · Cited by 340 · cited 1×
“Other post-translational STAT3 modifications are p300-mediated acetylation of K87 at the STAT3 NH2 terminus, which is required for IL-6-induced target gene activation [49], dimethylation of K49 at the NH2 terminus, which is crucial for the expression of many IL-6-dependent genes [50], monoubiquitination at K97, which…”
BackgroundSignal transducer and activator of transcription proteins in leukemias
Benekli, M., Baer, M. R., Baumann, H., & Wetzler, M. (2003) · Blood · doi:10.1182/blood-2002-04-1204 · Cited by 325
Jak-STAT Signaling Induced by the v- abl oncogene
Danial, N. N., Pernis, A., & Rothman, P. B. (1995) · Science · doi:10.1126/science.7569929 · Cited by 325
Weber-Nordt, R., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V, Mertelsmann, R., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.3.809.809 · Cited by 314
Stat3 controls lysosomal-mediated cell death in vivo
Kreuzaler, P. A., Staniszewska, A. D., Li, W., Omidvar, N., Kedjouar, B., Turkson, J., Poli, V., Flavell, R. A., Clarkson, R. W. E., & Watson, C. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2171 · Cited by 312
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 312
Shin, D.-S., Kim, H.-N., Shin, K. D., Yoon, Y. J., Kim, S.-J., Han, D. C., & Kwon, B.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2575 · Cited by 309
STAT3: A critical transcription activator in angiogenesis
Chen, Z., & Han, Z. C. (2008) · Medicinal Research Reviews · doi:10.1002/med.20101 · Cited by 305
Role of STAT3 in Type I Interferon Responses
Ho, H. H., & Ivashkiv, L. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511797200 · Cited by 302
Th17 cells: a new fate for differentiating helper T cells
Chen, Z., & O’Shea, J. J. (2008) · Immunologic Research · doi:10.1007/s12026-007-8014-9 · Cited by 300
Stem Cells and Pattern Formation in the Nervous System
Anderson, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00260-4 · Cited by 297
STAT‐mediated EGFR signaling in cancer
Quesnelle, K. M., Boehm, A. L., & Grandis, J. R. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21475 · Cited by 295
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20050465 · Cited by 291
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Leslie, K., Lang, C., Devgan, G., Azare, J., Berishaj, M., Gerald, W., Kim, Y. B., Paz, K., Darnell, J. E., Albanese, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2203 · Cited by 285
Lou, W., Ni, Z., Dyer, K., Tweardy, D. J., & Gao, A. C. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000215)42:3<239::aid-pros10>3.0.co;2-g · Cited by 278
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Burke, W. M., Jin, X., Lin, H.-J., Huang, M., Liu, R., Reynolds, R. K., & Lin, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204990 · Cited by 269
Johnson, R. W., Finger, E. C., Olcina, M. M., Vilalta, M., Aguilera, T., Miao, Y., Merkel, A. R., Johnson, J. R., Sterling, J. A., Wu, J. Y., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3408 · Cited by 262
Dechow, T. N., Pedranzini, L., Leitch, A., Leslie, K., Gerald, W. L., Linkov, I., & Bromberg, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404100101 · Cited by 254
Grunstein, J., Roberts, W. G., Mathieu-Costello, O. A., Hanahan, D., & Johnson, R. S. (1999) · PubMed · Cited by 247
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
Buchert, M., Burns, C. J., & Ernst, M. (2016) · Oncogene · doi:10.1038/onc.2015.150 · Cited by 243
JAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 242
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
Pilati, C., Amessou, M., Bihl, M. P., Balabaud, C., Van Nhieu, J. T., Paradis, V., Nault, J. C., Izard, T., Bioulac-Sage, P., Couchy, G., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110283 · Cited by 242
Karni, R., Jove, R., & Levitzki, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202835 · Cited by 242
Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grötzinger, J., Wollmer, A., Zhong, Z., Darnell, J. E., Graeve, L., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12999 · Cited by 239
Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S. B., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205132109 · Cited by 234
Watson, C., & Miller, W. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.162 · Cited by 226
Haura, E. B., Zheng, Z., Song, L., Cantor, A., & Bepler, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0827 · Cited by 223
Betz, U. A. K., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K., & Müller, W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1955 · Cited by 218
Robles, A. I., Rodriguez-Puebla, M. L., Glick, A. B., Trempus, C., Hansen, L., Sicinski, P., Tennant, R. W., Weinberg, R. A., Yuspa, S. H., & Conti, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.16.2469 · Cited by 217
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Kim, R. S., Avivar-Valderas, A., Estrada, Y., Bragado, P., Sosa, M. S., Aguirre-Ghiso, J. A., & Segall, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035569 · Cited by 212
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Wang, H., Wang, H., Zhang, W., Huang, H. J., Liao, W. S. L., & Fuller, G. N. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700123 · Cited by 212
Alvarez, J. V., Febbo, P. G., Ramaswamy, S., Loda, M., Richardson, A., & Frank, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4281 · Cited by 202
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 202
Kritikou, E. A., Sharkey, A., Abell, K., Came, P. J., Anderson, E., Clarkson, R. W. E., & Watson, C. J. (2003) · Development · doi:10.1242/dev.00578 · Cited by 201
Hazan-Halevy, I., Harris, D., Liu, Z., Liu, J., Li, P., Chen, X., Shanker, S., Ferrajoli, A., Keating, M. J., & Estrov, Z. (2010) · Blood · doi:10.1182/blood-2009-10-230060 · Cited by 198
Dolled-Filhart, M. P., Camp, R. L., Kowalski, D. P., Smith, B. L., & Rimm, D. L. (2003) · PubMed · Cited by 196
IL-6 is required for glioma development in a mouse model
Weissenberger, J., Loeffler, S., Kappeler, A., Kopf, M., Lukes, A., Afanasieva, T. A., Aguzzi, A., & Weis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207455 · Cited by 189
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
STAT 3 the oncogene – still eluding therapy?
Wake, M. S., & Watson, C. J. (2015) · The FEBS Journal · doi:10.1111/febs.13285 · Cited by 188
Siddiquee, K. A. Z., Gunning, P. T., Glenn, M., Katt, W. P., Zhang, S., Schroeck, C., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 187
Dong, Y., Lu, B., Zhang, X., Zhang, J., Lai, L., Li, D., Wu, Y., Song, Y., Luo, J., Pang, X., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq167 · Cited by 180
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Pencik, J., Schlederer, M., Gruber, W., Unger, C., Walker, S. M., Chalaris, A., Marié, I. J., Hassler, M. R., Javaheri, T., Aksoy, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms8736 · Cited by 170
Schaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Fortuitous convergences: the beginnings of JUN
Vogt, P. K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc818 · Cited by 167
MCL-1 inhibition in cancer treatment
Xiang, W., Yang, C., & Bai, L. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s146228 · Cited by 167
Itoh, M., Murata, T., Suzuki, T., Shindoh, M., Nakajima, K., Imai, K., & Yoshida, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209149 · Cited by 166
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
Bharadwaj, U., Eckols, T. K., Kolosov, M., Kasembeli, M. M., Adam, A., Torres, D., Zhang, X., Dobrolecki, L. E., Wei, W., Lewis, M. T., et al. (2015) · Oncogene · doi:10.1038/onc.2014.72 · Cited by 161
Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
Alle, K. M., Henshall, S. M., Field, A. S., & Sutherland, R. L. (1998) · PubMed · Cited by 159
Current status of SRC inhibitors in solid tumor malignancies
Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158
STAT3 negatively regulates thyroid tumorigenesis
Couto, J. P., Daly, L., de Almeida, A. P., Knauf, J. A., Fagin, J. A., Sobrinho-Simões, M. A., Lima, J. P., Máximo, V., Soares, P., Lyden, D. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201232109 · Cited by 153
Turkson, J., Zhang, S., Mora, L. B., Burns, A. C., Sebti, S. M., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 153
Therapeutic Targeting of the JAK / STAT Pathway
Aittomäki, S., & Pesu, M. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12164 · Cited by 152
Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a
Giraud, S., Bienvenu, F., Avril, S., Gascan, H., Heery, D. M., & Coqueret, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111486200 · Cited by 152
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7285 · Cited by 150
Zhang, X., Sun, Y., Pireddu, R., Yang, H., Urlam, M. K., Lawrence, H. R., Guida, W. C., Lawrence, N. J., & Sebti, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3175 · Cited by 149
STAT3-driven transcription depends upon the dimethylation of K49 by EZH2
Dasgupta, M., Dermawan, J. K. T., Willard, B. B., & Stark, G. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503152112 · Cited by 147
Timofeeva, O. A., Tarasova, N. I., Zhang, X., Chasovskikh, S., Cheema, A. K., Wang, H., Brown, M. L., & Dritschilo, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211805110 · Cited by 146
Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy
Bosch‐Barrera, J., & Menéndez, J. A. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.04.008 · Cited by 144
Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex
Yoshimatsu, T., Kawaguchi, D., Oishi, K., Takeda, K., Akira, S., Masuyama, N., & Gotoh, Y. (2006) · Development · doi:10.1242/dev.02419 · Cited by 140
Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 139
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 133
Identification of a High-Affinity Phosphopeptide Inhibitor of Stat3
Ren, Z., Cabell, L. A., Schaefer, T. S., & McMurray, J. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01050-8 · Cited by 128
Huang, W., Dong, Z., Wang, F., Peng, H., Liu, J., & Zhang, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500071v · Cited by 128
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
Guha, P., Gardell, J., Darpolor, J. K., Cunetta, M., Lima, M., Miller, G., Espat, N. J., Junghans, R. P., & Katz, S. C. (2018) · Oncogene · doi:10.1038/s41388-018-0449-z · Cited by 128
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 127
STAT3 Regulation of Glioblastoma Pathogenesis
de la Iglesia, N., Puram, S. V., & Bonni, A. (2009) · Current Molecular Medicine · doi:10.2174/156652409788488739 · Cited by 127
Epidermal Growth Factor Receptor–Mediated Stat3 Signaling Blocks Apoptosis in Head and Neck Cancer
Grandis, J. R., Zeng, Q., & Drenning, S. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200005000-00016 · Cited by 125
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Alexandrow, M. G., Song, L., Altiok, S., Gray, J., Haura, E. B., & Kumar, N. B. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834ef194 · Cited by 125
Rivat, C., Rodrigues-Ferreira, S., Erik, B., Piétu, G., Amélie, R., Redeuilh, G., Bracke, M., Gespach, C. P., & Attoub, S. (2005) · Cancer Research · doi:10.1158/0008-5472.195.65.1 · Cited by 125
Besser, D., Bromberg, J., Darnell, J. E., Jr., & Hanafusa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1401 · Cited by 123
Small Molecule Inhibitors of Stat3 Signaling Pathway
Deng, J. N., Grande, F., & Neamati, N. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006922 · Cited by 121
Kim, M., Nam, H.-J., Kim, H., Han, S., Im, S., Kim, T., Oh, D., & Bang, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.010 · Cited by 118
Huang, W., Dong, Z., Chen, Y., Wang, F., Wang, C. J., Peng, H., He, Y., Hangoc, G., Pollok, K. E., Sandusky, G. E., et al. (2015) · Oncogene · doi:10.1038/onc.2015.215 · Cited by 116
Herbeuval, J., Lelièvre, E., Lambert, C., Dy, M., & Genin, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4630 · Cited by 115
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Plimack, E. R., LoRusso, P. M., Mccoon, P. E., Tang, W., Krebs, A. D., Curt, G. A., & Eckhardt, S. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0198 · Cited by 115
Stat3 in Resident Macrophages as a Repressor Protein of Inflammatory Response
Matsukawa, A., Shinji, K. U. D. O., Maeda, T., Numata, K., Watanabe, H. A., Takeda, K., Akira, S., & Ito, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3354 · Cited by 113
Rivat, C., Rivat, C., Rodrigues-Ferreira, S., Rodrigues, S., Bruyneel, E. A., Erik, B., Piétu, G., Piétu, G., Robert, A., Amélie, R., et al. (2005) · PubMed · Cited by 110
Matsumura, Y., Kobayashi, T., Ichiyama, K., Yoshida, R., Hashimoto, M., Takimoto, T., Tanaka, K., Chinen, T., Shichita, T., Wyss‐Coray, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2170 · Cited by 109
Hayakawa, F., Sugimoto, K., Harada, Y., Hashimoto, N., Ohi, N., Kurahashi, S., & Naoe, T. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.63 · Cited by 108
STAT3: A multifaceted oncogene
Levy, D. E., & Inghirami, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604042103 · Cited by 107
Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck
Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., & Medveczky, P. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6677-6682.1997 · Cited by 105
Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene
Giraud, S., Hurlstone, A. F. L., Avril, S., & Coqueret, O. (2004) · Oncogene · doi:10.1038/sj.onc.1207972 · Cited by 105
Zhang, Y., Du, X., Wang, C., Lin, D., Ruan, X., Feng, Y., Huo, Y., Peng, H., Cui, J., Zhang, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.023 · Cited by 104
Liu, Y., Wang, X., Zeng, S., Zhang, X., Zhao, J., Zhang, X., Chen, X., Yang, W., Yang, Y., Dong, Z., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0959-0 · Cited by 99
Ivanov, V. N., Ronai, Z. A., & Ma, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108233200 · Cited by 95
Buerger, C., Nagel‐Wolfrum, K., Kunz, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301629200 · Cited by 94
Zong, C. S., Zeng, L., Jiang, Y., Sadowski, H. B., & Wang, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28065 · Cited by 92
Ranger, J. J., Levy, D. E., Shahalizadeh, S., Hallett, M. T., & Muller, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1684 · Cited by 92
Verstovšek, S., Manshouri, T., Quintás‐Cardama, A., Harris, D., Cortes, J. E., Giles, F. J., Kantarjian, H. M., Priebe, W., & Estrov, Z. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0524 · Cited by 87
Lee, J., Kim, J. C. K., Lee, S.-E., Quinley, C., Kim, H., Herdman, S., Corr, M., & Raz, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328831 · Cited by 76
Nam, S., Wen, W. X., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K., Eisenbrand, G., Li, H., Yuan, Y., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.013 · Cited by 75
Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer
Rao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000249 · Cited by 75
Sala, G. L., Michiels, C., Kükenshöner, T., Brandstoetter, T., Maurer, B., Koide, A., Lau, K., Pojer, F., Koide, S., Sexl, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17920-z · Cited by 75
The Janus Kinase Family and Signaling Through Members of the Cytokine Receptor Superfamily
Ihle, J. N. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-206-43757 · Cited by 74
Wen, X., Lin, H., Shih, H., Kung, H.-J., & Ann, D. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38204 · Cited by 72
Schuringa, J. J., Timmer, H., Luttickhuizen, D., Vellenga, E., & Kruijer, W. (2001) · Cytokine · doi:10.1006/cyto.2001.0856 · Cited by 71
Li, H., Huang, C., Huang, K., Wu, W. D., Jiang, T., Cao, J., Feng, Z., & Qiu, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025941 · Cited by 69
Ivanov, V. N., Zhou, H., Partridge, M. A., & Hei, T. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3883 · Cited by 69
Pectasides, E., Egloff, A. M., Sasaki, C. T., Kountourakis, P., Burtness, B. A., Fountzilas, G., Dafni, U. G., Zaramboukas, T., Rampias, T. N., Rimm, D. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2658 · Cited by 69
The Stat3 paradox: A killer and an oncogene
Resemann, H. K., Watson, C. J., & Lloyd‐Lewis, B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.029 · Cited by 68
Bohrer, L. R., Chuntova, P., Bade, L. K., Beadnell, T. C., Leon, R. P., Brady, N. J., Ryu, Y., Goldberg, J. E., Schmechel, S. C., Koopmeiners, J. S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2469 · Cited by 67
Okusaka, T., Ueno, H., Ikeda, M., Mitsunaga, S., Ozaka, M., Ishii, H., Yokosuka, O., Ooka, Y., Yoshimoto, R., Yanagihara, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12504 · Cited by 67
Oh, M., Park, H., Kim, N., Park, S., Park, I. Y., & Kim, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150557 · Cited by 66
Albasri, A., Seth, R., Jackson, D., Benhasouna, A., Crook, S., Nateri, A. S., Chapman, R., & Ilyas, M. (2009) · Journal of Pathology · doi:10.1002/path.2508 · Cited by 64
Liao, Y., Chen, N.-T., Shih, Y.-P., Dong, Y., & Lo, S. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0117 · Cited by 63
STAT3 can serve as a hit in the process of malignant transformation of primary cells
Demaria, M., Misale, S., Giorgi, C., Miano, V., Camporeale, A., Campisi, J., Pinton, P., & Poli, V. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.20 · Cited by 61
Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
Buettner, R., Corzano, R., Rashid, R., Lin, J., Senthil, M., Hedvat, M., Schroeder, A., Mao, A., Herrmann, A., Yim, J. H., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb100253e · Cited by 60
Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203549 · Cited by 59
Cten mRNA expression was correlated with tumor progression in lung cancers.
Sasaki, H., Moriyama, S., Mizuno, K., Yukiue, H., Konishi, A., Yano, M., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., et al. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00037-0 · Cited by 57
Chen, J., Nikolovska‐Coleska, Z., Yang, C., Gomez, C., Gao, W., Krajewski, K., Jiang, S., Roller, P. P., & Wang, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.096 · Cited by 57
Zhang, H.-F., Chen, Y., Wu, C., Wu, Z.-Y., Tweardy, D. J., Alshareef, A., Liao, L., Xue, Y.-J., Wu, J.-Y., Chen, B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1253 · Cited by 57
Ray, S., Zhao, Y., Jamaluddin, M., Edeh, C. B., Lee, C., & Brasier, A. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.007 · Cited by 56
Lund, T. C., Prator, P. C., Medveczky, M. M., & Medveczky, P. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1689-1694.1999 · Cited by 56
Prognostic Relevance of Tensin4 Expression in Human Gastric Cancer
Sakashita, K., Mimori, K., Tanaka, F., Kamohara, Y., Inoue, H., Sawada, T., Hirakawa, K., & Mori, M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9989-8 · Cited by 54
How should we define STAT3 as an oncogene and as a potential target for therapy?
Sellier, H., Rébillard, A., Guette, C., Barré, B., & Coqueret, O. (2013) · JAK-STAT · doi:10.4161/jkst.24716 · Cited by 54
Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 54
Of alphas and betas: distinct and overlapping functions of STAT3 isoforms
Dewilde, S. (2008) · Frontiers in Bioscience · doi:10.2741/3170 · Cited by 53
Epstein–Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
Banerjee, A. S., Pal, A. D., & Banerjee, S. (2013) · Virology · doi:10.1016/j.virol.2013.05.020 · Cited by 52
Trevino, J. G., Gray, M. J., Nawrocki, S. T., Summy, J. M., Lesslie, D. P., Evans, D. B., Sawyer, T. K., Shakespeare, W. C., Watowich, S. S., Chiao, P. J., et al. (2006) · Angiogenesis · doi:10.1007/s10456-006-9038-9 · Cited by 52
Targeting STAT3 in Cancer with Nucleotide Therapeutics
Lau, Y.-T. K., Ramaiyer, M. S., Johnson, D. E., & Grandis, J. R. (2019) · Cancers · doi:10.3390/cancers11111681 · Cited by 52
Cten mRNA Expression Is Correlated with Tumor Progression in Thymoma
Sasaki, H., Yukiue, H., Kobayashi, Y., Fukai, I., & Fujii, Y. (2003) · Tumor Biology · doi:10.1159/000076141 · Cited by 51
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas
Pan, Y.-R., Chen, C.-C., Chan, Y.-T., Wang, H.-J., Chien, F.-T., Chen, Y.-L., Liu, J.-L., & Yang, M.-H. (2018) · Nature Communications · doi:10.1038/s41467-018-06134-z · Cited by 47
Shao, H., Quintero, A. J., & Tweardy, D. J. (2001) · Blood · doi:10.1182/blood.v98.13.3853 · Cited by 43
Nepomuceno, R. R., Snow, A. L., Beatty, P. R., Krams, S. M., & Martinez, O. M. (2002) · Transplantation · doi:10.1097/00007890-200208150-00017 · Cited by 42
Sun, J., Du, Y., Song, Q., Jing, N., Guan, P., Guo, J., Wang, X., Yang, J., & Zhao, C. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy174 · Cited by 42
Barbieri, I., Quaglino, E., Maritano, D., Pannellini, T., Riera, L., Cavallo, F., Forni, G., Musiani, P., Chiarle, R., & Poli, V. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20605 · Cited by 40
Kumar, A., & Bora, U. (2012) · Bioinformation · doi:10.6026/97320630008988 · Cited by 36
Cited by
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Advances in the role of STAT3 in macrophage polarization
Xia, T., Zhang, M., Lei, W., Yang, R., Fu, S., Fan, Z., Yang, Y., & Zhang, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160719 · Cited by 284
Metadata
- Authors
- Tolomeo, M., & Cascio, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-01-09
- Volume
- 22
- Issue
- 2
- Pages
- 603
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3119177747
- Cited by
- 318
- References
- 210
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.